Codice QR

Liquid biopsies and minimal residual disease in myeloid malignancies

Minimal residual disease (MRD) assessment through blood component sampling by liquid biopsies (LBs) is increasingly being investigated in myeloid malignancies. Blood components then undergo molecular analysis by flow cytometry or sequencing techniques and can be used as a powerful tool for prognosti...

Descrizione completa

Salvato in:
Autori principali: Sabine Allam, Kristina Nasr, Farhan Khalid, Zunairah Shah, Mahammed Ziauddin Khan Suheb, Sana Mulla, Sindhu Vikash, Maroun Bou Zerdan, Faiz Anwer, Chakra P. Chaulagain
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2023-05-01
Serie:Frontiers in Oncology
Soggetti:
liquid biopsies
minimal residual disease (MRD)
acute myeloid leukemia
acute myeloid leukemia (AML)
myelodysplastic syndromes (MDS)
myeloid malignancies
Accesso online:https://www.frontiersin.org/articles/10.3389/fonc.2023.1164017/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi